0
Sickle Cell Disease Treatment Centers Act of 2022
12/29/2022, 12:33 PM
Summary of Bill HR 8855
These treatment centers will offer a range of services, including medical treatment, counseling, and support services for patients and their families. The bill also calls for increased research funding to further understand and develop new treatments for sickle cell disease.
Additionally, the bill emphasizes the importance of education and outreach efforts to raise awareness about sickle cell disease and promote early detection and treatment. It also seeks to address disparities in access to care for individuals with sickle cell disease, particularly in underserved communities. Overall, the Sickle Cell Disease Treatment Centers Act of 2022 aims to improve the quality of life for individuals with sickle cell disease by providing specialized care, increasing research funding, and promoting education and outreach efforts.
Congressional Summary of HR 8855
Sickle Cell Disease Treatment Centers Act of 2022
This bill directs the Department of Health and Human Services to award grants for establishing sickle cell disease treatment centers that operate using a hub-and-spoke framework to provide integrated, longitudinal health care for patients with the disease and individuals with sickle cell trait. Grant recipients must be networks comprised of (1) a hospital, clinic, or university health center; (2) at least one federally qualified health center or other health care organization that incorporates community health workers into the care team; and (3) at least one community-based organization.
Sickle cell disease is an inherited blood disorder that can lead to pain, anemia, infections, and stroke.
